Irbesartan Hydrochloorthiazide Torrent 300 mg/25 mg filmomhulde tabletten

Irbesartan Hydrochlorothiazide Heumann is a combination of two active substances, irbesartan and hydrochlorothiazide.

Irbesartan belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body that binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Irbesartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower.

Hydrochlorothiazide is one of a group of medicines (called thiazide diuretics) that causes increased urine output and so causes a lowering of blood pressure.

The two active ingredients in Irbesartan Hydrochlorothiazide Heumann work together to lower blood pressure further than if either was given alone.

Irbesartan Hydrochlorothiazide Heumann is used to treat high blood pressure, when treatment with irbesartan or hydrochlorothiazide alone did not provide adequate control of your blood pressure.

Do not take Irbesartan Hydrochlorothiazide Heumann

• if you are allergic to irbesartan or any of the other ingredients of this medicine (listed in

Irbesartan Hydrochlorothiazide Heumann, 150/12.5-300/12.5-300/25 mg, film-coated tablets – NL/H/2067/001-003/DC DCP pl

DCP/p/010/13/2

section 6)

• if you are allergic to hydrochlorothiazide or any other sulfonamide-derived medicines
• if you are more than 3 months pregnant. (It is also better to avoid Irbesartan Hydrochlorothiazide Heumann in early pregnancy – see pregnancy section)
• if you have severe liver or kidney problems
• if you have difficulty in producing urine
• if your doctor determines that you have persistently high calcium or low potassium levels in your blood

Children and adolescents

Irbesartan Hydrochlorothiazide Heumann should not be given to children and adolescents (under 18 years).

Warnings and precautions

Talk to your doctor before taking Irbesartan Hydrochlorothiazide Heumann and if any of the following apply to you:

• if you get excessive vomiting or diarrhoea
• if you suffer from kidney problems or have a kidney transplant
• if you suffer from heart problems
• if you suffer from liver problems
• if you suffer from diabetes
• if you suffer from lupus erythematosus (also known as lupus or SLE)
• if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).

You must tell your doctor if you think you are (or might become) pregnant. Irbesartan Hydrochlorothiazide Heumann is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).

You should also tell your doctor:

• if you are on a low-salt diet
• if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Irbesartan Hydrochlorothiazide Heumann)
• if you experience an increased sensitivity of the skin to the sun with symptoms of sunburn (such as redness, itching, swelling, blistering) occurring more quickly than normal
• if you are going to have an operation (surgery) or be given anaesthetics
• if you have changes in your vision or pain in one or both of your eyes while taking Irbesartan Hydrochlorothiazide Heumann. This could be a sign that you are developing glaucoma, increased pressure in your eye(s). You should discontinue Irbesartan Hydrochlorothiazide Heumann treatment and seek medical attention.

Other medicines and Irbesartan Hydrochlorothiazide Heumann

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Diuretic agents such as the hydrochlorothiazide contained in Irbesartan Hydrochlorothiazide Heumann may have an effect on other medicines. Preparations containing lithium should not be taken with Irbesartan Hydrochlorothiazide Heumann without close supervision by your doctor.

Irbesartan Hydrochlorothiazide Heumann, 150/12.5-300/12.5-300/25 mg, film-coated tablets – NL/H/2067/001-003/DC DCP pl

DCP/p/010/13/2

You may need to have blood checks if you take:

• potassium supplements
• salt substitutes containing potassium
• potassium sparing medicines or other diuretics (water tablets)
• some laxatives
• medicines for the treatment of gout
• therapeutic vitamin D supplements
• medicines to control heart rhythm
• medicines for diabetes (oral agents or insulins)
• carbamazepine (a medicine for the treatment of epilepsy).

It is also important to tell your doctor if you are taking other medicines to reduce your blood pressure, steroids, medicines to treat cancer, pain killers, arthritis medicines, or colestyramine and colestipol resins for lowering blood cholesterol.

Irbesartan Hydrochlorothiazide Heumann with food and drink

Irbesartan Hydrochlorothiazide Heumann can be taken with or without food.

Due to the hydrochlorothiazide contained in Irbesartan Hydrochlorothiazide Heumann, if you drink alcohol while on treatment with this medicine, you may have an increased feeling of dizziness on standing up, specially when getting up from a sitting position.

Pregnancy and breast-feeding Pregnancy

You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Irbesartan Hydrochlorothiazide Heumann before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Irbesartan Hydrochlorothiazide Heumann. Irbesartan Hydrochlorothiazide Heumann is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.

Breast-feeding

Tell your doctor if you are breast-feeding or about to start breast-feeding. Irbesartan Hydrochlorothiazide Heumann is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.

Driving and using machines

No studies on the effects on the ability to drive and use machines have been performed. Irbesartan Hydrochlorothiazide Heumann is unlikely to affect your ability to drive or use machines. However, occasionally dizziness or weariness may occur during treatment of high blood pressure. If you experience these, talk to your doctor before attempting to drive or use machines.

Irbesartan Hydrochlorothiazide Heumann contains lactose. If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose), contact your doctor before taking this medicine.

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Dosage

The recommended dose of Irbesartan Hydrochlorothiazide Heumann is one or two tablets of

Irbesartan Hydrochlorothiazide Heumann, 150/12.5-300/12.5-300/25 mg, film-coated tablets – NL/H/2067/001-003/DC DCP pl

DCP/p/010/13/2

150/12.5 mg a day, or one tablet of 300/12.5 mg or 300/25 mg a day. Irbesartan Hydrochlorothiazide Heumann will usually be prescribed by your doctor when your previous treatment did not reduce your blood pressure enough. Your doctor will instruct you how to switch from the previous treatment to Irbesartan Hydrochlorothiazide Heumann.

Method of administration

Irbesartan Hydrochlorothiazide Heumann is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g. one glass of water). You can take Irbesartan Hydrochlorothiazide Heumann with or without food. Try to take your daily dose at about the same time each day. It is important that you continue to take Irbesartan Hydrochlorothiazide Heumann until your doctor tells you otherwise.

The maximal blood pressure lowering effect should be reached 6-8 weeks after beginning treatment.

Children and adolescents should not take Irbesartan Hydrochlorothiazide Heumann Irbesartan Hydrochlorothiazide Heumann should not be given to children and adolescents under 18 years of age. If a child swallows some tablets, contact your doctor immediately.

If you take more Irbesartan Hydrochlorothiazide Heumann than you should

If you accidentally take too many tablets, contact your doctor immediately.

If you forget to take Irbesartan Hydrochlorothiazide Heumann

If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of these effects may be serious and may require medical attention.

Rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/or tongue have been reported in patients taking irbesartan. If you get any of the above symptoms or get short of breath, stop taking Irbesartan Hydrochlorothiazide Heumann and contact your doctor immediately.

Side effects reported in clinical studies for patients treated with irbesartan/hydrochlorothiazide were:

Common side effects (affect 1 to 10 users in 100)

• nausea/vomiting
• abnormal urination
• fatigue
• dizziness (including when getting up from a lying or sitting position)
• blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase) or raised levels of substances that measure kidney function (blood urea

nitrogen, creatinine).

If any of these side effects causes you problems, talk to your doctor.

Uncommon side effects (affect 1 to 10 users in 1,000)

• diarrhoea
• low blood pressure
• fainting
• heart rate increased
• flushing

Irbesartan Hydrochlorothiazide Heumann, 150/12.5-300/12.5-300/25 mg, film-coated tablets – NL/H/2067/001-003/DC DCP pl

DCP/p/010/13/2

• swelling
• sexual dysfunction (problems with sexual performance)
• blood tests may show lowered levels of potassium and sodium in your blood. If any of these side effects causes you problems, talk to your doctor.

Side effects reported since the launch of irbesartan with hydrochlorothiazide

Some undesirable effects have been reported since marketing of Irbesartan/hydrochlorothiazide. Undesirable effects where the frequency is not known are: headache, ringing in the ears, cough, taste disturbance, indigestion, pain in joints and muscles, liver function abnormal and impaired kidney function, increased level of potassium in your blood and allergic reactions such as rash, hives, swelling of the face, lips, mouth, tongue or throat. Uncommon cases of jaundice (yellowing of the skin and/or whites of the eyes) have also been reported.

As for any combination of two active substances, side effects associated with each individual component cannot be excluded.

Side effects associated with irbesartan alone

In addition to the side effects listed above, chest pain has also been reported.

Side effects associated with hydrochlorothiazide alone

Loss of appetite; stomach irritation; stomach cramps; constipation; jaundice (yellowing of the skin and/or whites of the eyes); inflammation of the pancreas characterised by severe upper stomach pain, often with nausea and vomiting; sleep disorders; depression; blurred vision; lack of white blood cells, which can result in frequent infections, fever; decrease in the number of platelets (a blood cell essential for the clotting of the blood), decreased number of red blood cells (anaemia) characterised by tiredness, headaches, being short of breath when exercising, dizziness and looking pale; kidney disease; lung problems including pneumonia or build-up of fluid in the lungs; increased sensitivity of the skin to the sun; inflammation of blood vessels; a skin disease characterized by the peeling of the skin all over the body; cutaneous lupus erythematosus, which is identified by a rash that may appear on the face, neck, and scalp; allergic reactions; weakness and muscle spasm; altered heart rate; reduced blood pressure after a change in body position; swelling of the salivary glands; high sugar levels in the blood; sugar in the urine; increases in some kinds of blood fat; high uric acid levels in the blood, which may cause gout.

It is known that side effects associated with hydrochlorothiazide may increase with higher doses of hydrochlorothiazide.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

Keep this medicine out of the sight and reach of children.

This medicinal product does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the carton and on the blister. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater <or household waste>. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Irbesartan Hydrochlorothiazide Heumann, 150/12.5-300/12.5-300/25 mg, film-coated tablets – NL/H/2067/001-003/DC DCP pl

DCP/p/010/13/2

What Irbesartan Hydrochlorothiazide Heumann contains

• The active substances are irbesartan and hydrochlorothiazide. Irbesartan Hydrochlorothiazide Heumann 150 mg/12.5 mg: Each film-coated tablet contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide. Irbesartan Hydrochlorothiazide Heumann 300 mg/12.5 mg: Each film-coated tablet contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide. Irbesartan Hydrochlorothiazide Heumann 300 mg/25 mg: Each film-coated tablet contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
• The other ingredients are: Core: Lactose monohydrate Croscarmellose sodium Povidone K-30 Iron oxide red (E 172) Iron oxide yellow (E172) Magnesium stearate Film-Coat: For Irbesartan Hydrochlorothiazide Heumann 150 mg/12,5 mg and 300 mg/12,5 mg: Opadry II pink: Iron oxide red (E172) Iron oxide yellow (E172) Hypromellose 5cP Lactose monohydrate Macrogol 4000 Titanium dioxide (E171) For Irbesartan Hydrochlorothiazide Heumann 300 mg/25 mg: Opadry II brown: Iron oxide red (E172) Iron oxide yellow (E172) Iron oxide black (E172) Hypromellose 5cP Lactose monohydrate Macrogol 4000 Titanium dioxide (E171).

What Irbesartan Hydrochlorothiazide Heumann looks like and contents of the pack

Irbesartan Hydrochlorothiazide Heumann 150 mg/12.5 mg film-coated tablets:

Pinkish orange coloured, oval shaped, biconvex film-coated tablets, debossed with “L183” on one side and plain on other side.

Irbesartan Hydrochlorothiazide Heumann 300 mg/12.5 mg film-coated tablets:

Pale pink with orange shade coloured, oval shaped, biconvex film-coated tablets, debossed with “L184” on one side and plain on other side.

Irbesartan Hydrochlorothiazide Heumann 300 mg/25 mg film-coated tablets:

Pinkish brown, oval shaped, biconvex film-coated tablets, debossed with “L185” on one side and plain on other side.

Irbesartan Hydrochlorothiazide Heumann, 150/12.5-300/12.5-300/25 mg, film-coated tablets – NL/H/2067/001-003/DC DCP pl

DCP/p/010/13/2

Pack sizes: 10; 14; 28; 30; 56; 60; 98; 100 film-coated tablets

Not all pack sizes may be marketed.

Marketing authorisation holder

Torrent Pharma GmbH

Südwestpark 50, 90449 Nürnberg

Duitsland

Manufacturer

Heumann Pharma GmbH & Co. Generica KG

Südwestpark 50, 90449 Nürnberg

Duitsland

Torrent Pharma GmbH

Südwestpark 50, 90449 Nürnberg

Duitsland

Dit geneesmiddel is geregistreerd onder:

Irbesartan Hydrochloorthiazide Torrent 150 mg/12,5 mg filmomhulde tabletten: RVG 107931

Irbesartan Hydrochloorthiazide Torrent 300 mg/12,5 mg filmomhulde tabletten: RVG 107933 Irbesartan Hydrochloorthiazide Torrent 300 mg/25 mg filmomhulde tabletten: RVG 107935

This medicinal product is authorised in the Member States of the EEA under the following names:

The Netherlands: Irbesartan Hydrochloorthiazide Torrent 150/300 mg/12,5/25 mg filmomhulde tabletten

Germany: Irbesartan/Hydrochlorothiazid Heumann 150/300 mg/12,5/25 mg Filmtabletten Lithuania: Irbesartanas Hidrochlorotiazidas Torrent 150/300 mg/12,5/25 mg plėvele dengtos tabletės Romania: Irbesartan HidroclorotiazidăTorrent 150/300 mg/12,5/25 mg comprimate filmate

United Kingdom: Irbesartan Hydrochorothiazide 150/300 mg/12.5/25 mg Film-coated Tablets

Deze bijsluiter is voor het laatst goedgekeurd in oktober 2013.